TITLE

Is FDG-PET indicated for superficial esophageal cancer?

AUTHOR(S)
Little, Sherard G.; Rice, Thomas W.; Bybel, Bohdan; Mason, David P.; Murthy, Sudish C.; Falk, Gary W.; Rybicki, Lisa A.; Blackstone, Eugene H.
PUB. DATE
May 2007
SOURCE
European Journal of Cardio-Thoracic Surgery;May2007, Vol. 31 Issue 5, p792
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: To ascertain whether fluorodeoxyglucose positron emission tomography is indicated for clinical staging of superficial cancer, we sought to determine if it accurately classifies tumor (T), regional nodal (N), and distant metastases (M), including distinguishing high-grade dysplasia (Tis) from invasive cancer (T1). Methods: Fifty-eight superficial esophageal cancer patients had preoperative positron emission tomography, 53 (91%) fused with computed tomography. Tumor characteristics, esophagoscopy findings, and pTNM were compared with positron emission tomography cTNM. pT1 was subdivided into intramucosal cancers with lamina propria or muscularis mucosa invasion and submucosal cancers with inner or outer invasion. Results: Fluorodeoxyglucose uptake increased with pT, from 5/11 (45%) for pTis to 11/16 (69%) for pT1 (outer submucosa), P =0.07, as it did for standardized uptake value, median 0 for pTis to 2.7 for pT1 (outer submucosa), P =0.06. Positron emission tomography could not differentiate Tis (5/11, 45%) from T1 (26/47, 55%; P = 0.03). Regional nodal fluorodeoxyglucose uptake in three patients (standardized uptake value 2.8, 4.9, 11) was false positive; in six pN1 patients, it was false negative. Positron emission tomography had 0% sensitivity and positive predictive value for N1. There were no distant metastases; one patient developed a pulmonary metastasis 15 months postoperatively. Positron emission tomography detected three (5%) distant hypermetabolic sites, all synchronous tumors (papillary thyroid cancer, adrenal pheochromocytoma, rectal adenoma). Only increasing tumor length was related to greater fluorodeoxyglucose uptake (P = 0.004) and higher standardized uptake value (P = 0.001). Conclusions: Because positron emission tomography can neither differentiate pTis from T1 nor classify T, N, and M, it is not indicated in staging superficial esophageal cancer. Finding a synchronous primary tumor in approximately every 20th patient is its only benefit. Better, less expensive screening tools are available for common synchronous malignancies.
ACCESSION #
24611820

 

Related Articles

  • Molecular Biotheranostic Approaches of Cancers Using LAT Kit Probes. Kong, Fan-Lin; Yang, David J.; Ali, Mohammad; Tian, Mei; Huang, Wen-Chien; Kim, E. Edmund // Current Medical Imaging Reviews;2010, Vol. 6 Issue 1, p46 

    Purpose: Positron emission tomography (PET) and single photon emission computed tomography (SPECT) tracers have been applied to pharmacokinetic, pharmacodynamic, dose-finding, and proof-of-concept studies. PET/SPECT tracers could non-invasively assess treatment endpoints for diseases which used...

  • FDG-PET and PET/CT - Part II. Takalkar, Amol M.; El-Haddad, Ghassan; Lilien, David L. // Indian Journal of Radiology & Imaging;Feb2008, Vol. 18 Issue 1, p17 

    The article discusses the present clinical applications of FDG-PET and PET/CT in certain malignancies specifically head and neck cancer, lung cancer, lymphoma and melanoma. It says that FDG-PET was shown to be useful in other neoplasms like gastric cancer, soft tissue sarcomas and others. It...

  • Staging of Breast Cancer with 18F-FDG PET and PET/CT. Aukema, Tjeerd S.; Rutgers, Emiel J. T.; Vogel, Wouter V.; Olmos, Renato A. Vald�s // Current Medical Imaging Reviews;2009, Vol. 5 Issue 4, p203 

    Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) has been recognised as a sensitive tool for the staging of various malignancies, such as lung carcinoma, lymphoma, and esophageal cancer. Its role in staging process of breast cancer however is...

  • 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. Sugiyama, Masahiro; Sakahara, Harumi; Torizuka, Tatsuo; Kanno, Toshihiko; Nakamura, Fumitoshi; Futatsubashi, Masami; Nakamura, Satoshi // Journal of Gastroenterology;2004, Vol. 39 Issue 10, p961 

    Background. Positron emission tomography (PET) with 18F-fluoro-2-deoxy-d-glucose (18F-FDG) is useful in detecting distant metastases from a variety of malignancies. However, its efficiency in detecting distant metastases from hepatocellular carcinoma (HCC) has not been investigated. The aim of...

  • Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of 18F-FDG PET and extended-field multi-detector row CT. Shu-Hang Ng; Sheng-Chieh Chan; Chun-Ta Liao; Tung-Chieh Chang, Joseph; Sheung-Fat Ko; Hung-Ming Wang; Shu-Chyn Chin; Chin-Yu Lin; Shiang-Fu Huang; Tzu-Chen Yen // Neuroradiology;Nov2008, Vol. 50 Issue 11, p969 

    Patients with oropharyngeal or hypopharyngeal squamous cell carcinoma (SCC) have a high risk of having distant metastases or second primary tumors. We prospectively evaluate the clinical usefulness of 18F-fluoro-2-deoxyglucose positron emission tomography (18F-FDG PET), extended-field...

  • Osteoblastic bone metastases in breast cancer: is not seeing believing? Fogelman, Ignac // European Journal of Nuclear Medicine & Molecular Imaging;Nov2005, Vol. 32 Issue 11, p1250 

    The article comments on the use of positron emission tomography (PET) in the practice of oncology. It is important to consider various tumors individually and try to be aware of the factors which can influence the visualization of bone metastases. It is also observed that some sclerotic bone...

  • Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Verboom, Paul; Tinteren, Harm Van; Hoekstra, Otto S.; Smit, Egbert F.; Bergh, Jan H. A. M. Van Den; Schreurs, Ad J. M.; Stallaert, Rovand A. L. M.; Vethoven, Piet C. M. Van; Comans, Emile F I.; Diepenhorst, Fred W.; Van Mourik, Johan C.; Postmus, Pieter E.; Boers, Maarten; Grijseels, Els W. M.; Teule, Gerrit J. J.; Groot, Carin A. Uyl-de // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 11, p1444 

    Currently, up to 50% of the operations in early-stage non-small cell lung cancer (NSCLC) are futile owing to the presence of locally advanced tumour or distant metastases. More accurate pre-operative staging is required in order to reduce the number of futile operations. The cost-effectiveness...

  • Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Veit, Patrick; Antoch, Gerald; Stergar, Hrvoje; Bockisch, Andreas; Forsting, Michael; Kuehl, Hilmar // European Radiology;Jan2006, Vol. 16 Issue 1, p80 

    The aim of this study was to determine the accuracy of dual-modality positron emission tomography(PET)/computed tomography (CT) in the detection of residual tumor after radiofrequency ablation (RFA) of liver metastasis of colorectal cancer. Eleven patients with 16 hepatic metastases (mean size...

  • F-18 fluorodeoxyglucose positron emission tomography "super scan" in a patient of metastatic primitive neuroectodermal tumor of the kidney. Malhotra, Gaurav; Swami, Archana; Shah, Pinky; Mittal, Neha; Gandhi, Sunny J.; Tiwari, B. P.; Jatale, Praful V.; Asopa, Ramesh V. // Indian Journal of Nuclear Medicine;Apr2012, Vol. 27 Issue 2, p115 

    We report F-18 fluorodeoxyglucose (FDG) "positron emission tomography (PET) super scan" akin to "super scan" of conventional skeletal scintigraphy, in a rare case of primitive neuroectodermal tumor (PNET) of the kidney. A twelve year old male patient of metastatic PNET of the kidney was...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics